journal article·2020-02

Functionally modified magnetic nanoparticles for effective siRNA delivery to prostate cancer cells in vitro

Raju Panday, Ahmed Mohammed Elamin Abdalla, Miao Yu, Xiaohong Li, Chenxi Ouyang, Guang Yang

Publisher page

Abstract

Different types of siRNA delivery vehicles including nanoparticles have been synthesized and utilized for prostate cancer gene therapy. However, one of the most common limitations being faced is the toxicity of cationic polymers toward the cells. In the current study, magnetic nanoparticles were prepared and conjugated with cationic polymer, polyethylenimine. Then polyethylene glycol was conjugated with polyethylenimine to improve the biocompatibility of nanoparticles. The transmission electron microscopy size of nanoparticles was found to be 15.82 (±9.07) nm, while hydrodynamic size was about 79.20 (±0.68) nm. Zeta potential analysis of polyethylenimine and polyethylene glycol-coated nanoparticles was +31.4 (±0.62) and +5.65 (±0.76) mV, respectively. Fourier transform infrared spectroscopy and 1H nuclear magnetic resonance confirmed the presence of polyethylene glycol and polyethylenimine polymers in magnetic nanoparticles. Cell viability test in mouse fibroblast NIH 3T3 and prostate cancer PC3 cells showed an increased in biocompatibility of functionally modified polyethylene glycol–polyethylenimine–Fe 3 O 4 nanoparticles. siRNA targeting a disintegrin and metalloproteinase 10 (ADAM10) was successfully loaded into the polyethylene glycol–polyethylenimine–Fe 3 O 4 nanoparticles and delivered to PC3 cells. The results clearly demonstrated a significant decrease in cell viability, which increased within a certain siRNA concentration. The inhibitory concentration (IC50) value for ADAM10 siRNA was calculated to be 15.83 nM after 72 h. Confocal microscopy confirmed the delivery of siRNA-loaded nanoparticles intracellularly to the tumor cells cytosol. This magnetic system can be used as a powerful platform to inhibit cancer cells progression.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China

Department of Biology, National Forensic Science Laboratory, Kathmandu, Nepal

Department of Biochemistry, College of Applied Science, University of Bahri, Khartoum, Sudan

Department of Vascular Surgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China

Department of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Funding

National Natural Science Foundation of China · China Postdoctoral Science Foundation

References (40)

Show source-provided references
1. 10.1016/S0140-6736(14)61947-410.1016/S0140-6736(14)61947-4 ↗
2. 10.1016/j.colsurfb.2016.03.07110.1016/j.colsurfb.2016.03.071 ↗
3. 10.1016/j.maturitas.2012.01.01610.1016/j.maturitas.2012.01.016 ↗
4. 10.1016/j.apsb.2015.03.00110.1016/j.apsb.2015.03.001 ↗
5. 10.1016/j.cis.2017.05.00310.1016/j.cis.2017.05.003 ↗
6. 10.1016/j.biomaterials.2014.05.06810.1016/j.biomaterials.2014.05.068 ↗
7. 10.1016/j.ijpharm.2017.04.00810.1016/j.ijpharm.2017.04.008 ↗
8. Ewe A, Höbel S, Heine C, et al. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model. Drug Deliv Transl Res 2017; 7: 206–216.10.1007/s13346-016-0306-y ↗
9. 10.1016/j.jconrel.2015.08.03210.1016/j.jconrel.2015.08.032 ↗
10. 10.1038/mtna.2014.910.1038/mtna.2014.9 ↗
11. 10.1016/j.biomaterials.2013.07.07010.1016/j.biomaterials.2013.07.070 ↗
12. 10.1016/j.nano.2018.06.00910.1016/j.nano.2018.06.009 ↗
13. 10.3892/or.2014.350310.3892/or.2014.3503 ↗
14. 10.1016/j.bbcan.2010.02.00210.1016/j.bbcan.2010.02.002 ↗
15. Qu MIN, Qiu BO, Xiong W, et al. Expression of a-disintegrin and metalloproteinase 10 correlates with grade of malignancy in human glioma. Oncol Lett 2015; 9: 2157–2162.10.3892/ol.2015.2993 ↗
16. 10.1111/j.1349-7006.2007.00601.x10.1111/j.1349-7006.2007.00601.x ↗
17. 10.1016/j.bbamcr.2017.06.00510.1016/j.bbamcr.2017.06.005 ↗
18. 10.3892/ol.2014.181010.3892/ol.2014.1810 ↗
19. 10.1371/journal.pone.006136610.1371/journal.pone.0061366 ↗
20. 10.1016/j.jconrel.2005.07.01510.1016/j.jconrel.2005.07.015 ↗
21. 10.1021/la702887m10.1021/la702887m ↗
22. Lakshmanan R, Sanchez-Dominguez M, Matutes-Aquino JA, et al. Removal of total organic carbon from sewage wastewater using poly(ethylenimine)-functionalized magnetic nanoparticles. Langmuir 2014; 304: 1036–1044.10.1021/la404076n ↗
23. 10.1021/bm101244j10.1021/bm101244j ↗
24. 10.1016/j.canlet.2005.10.01910.1016/j.canlet.2005.10.019 ↗
25. 10.1016/j.msec.2016.09.05210.1016/j.msec.2016.09.052 ↗
26. 10.1016/j.colsurfb.2014.08.01510.1016/j.colsurfb.2014.08.015 ↗
27. 10.1016/j.msec.2014.12.02610.1016/j.msec.2014.12.026 ↗
28. 10.1016/j.ejmp.2014.05.01210.1016/j.ejmp.2014.05.012 ↗
29. Wang X, Zhu L, Hou X, et al. Polyethylenimine mediated magnetic nanoparticles for combined intracellular imaging, siRNA delivery and anti-tumor therapy. RSC Adv 2015; 5: 101569–101581.10.1039/C5RA18464A ↗
30. 10.1016/j.jmmm.2006.10.119410.1016/j.jmmm.2006.10.1194 ↗
31. 10.1042/bj2003125310.1042/bj20031253 ↗
32. 10.1016/j.ijpharm.2016.03.01410.1016/j.ijpharm.2016.03.014 ↗
33. 10.1016/S1003-6326(08)60069-210.1016/S1003-6326(08)60069-2 ↗
34. Chen Y, Lian G, Liao C. Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo. J Gastroenterol 2013; 48: 809–821.10.1007/s00535-012-0713-x ↗
35. 10.1016/j.actbio.2012.07.01510.1016/j.actbio.2012.07.015 ↗
36. 10.1016/j.matchemphys.2015.05.01810.1016/j.matchemphys.2015.05.018 ↗
37. 10.1016/j.msec.2017.05.07910.1016/j.msec.2017.05.079 ↗
38. Joubran S, Zigler M, Pessah N, et al. Optimization of liganded polyethylenimine polyethylene glycol 2 vector for nucleic acid delivery. Bioconjugate Chem 2014; 259: 1644–1654.10.1021/bc500252a ↗
39. 10.1021/am302883m10.1021/am302883m ↗
40. 10.1021/bm300690310.1021/bm3006903 ↗